ag 127 has been researched along with Leukemia, Pre-B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goi, K; Inukai, T; Kagami, K; Kojika, S; Lijima, K; Miyamoto, N; Nakamura, M; Nakazawa, S; Sugita, K; Tezuka, T | 1 |
1 other study(ies) available for ag 127 and Leukemia, Pre-B-Cell
Article | Year |
---|---|
The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.
Topics: Antineoplastic Agents; Cell Division; Chromosomes, Human, Pair 11; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Leukemia, Lymphoid; Philadelphia Chromosome; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Translocation, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrphostins | 2001 |